Published in Curr Drug Deliv on April 01, 2010
Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer (2011) 1.16
Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model. PLoS One (2012) 0.77
Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen. Int J Nanomedicine (2017) 0.75
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem (2006) 1.23
Modern subunit vaccines: development, components, and research opportunities. ChemMedChem (2013) 1.22
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis (2007) 1.16
Self-adjuvanting lipopeptide vaccines. Curr Med Chem (2008) 1.10
Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother (2013) 1.10
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol (2003) 1.06
Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv (2006) 1.01
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano (2012) 0.97
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology (2012) 0.94
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. J Med Chem (2007) 0.94
Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew Chem Int Ed Engl (2010) 0.94
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. Bioorg Med Chem (2008) 0.92
Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res (2012) 0.92
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr Drug Deliv (2005) 0.91
Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine. J Control Release (2009) 0.90
Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol (2005) 0.89
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun (2002) 0.87
Chemical methods for peptide and protein production. Molecules (2013) 0.87
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One (2012) 0.87
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. Exp Eye Res (2004) 0.87
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships. Front Immunol (2013) 0.86
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun (2003) 0.85
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. J Med Chem (2012) 0.85
In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem (2008) 0.85
Peptide-based subunit nanovaccines. Curr Drug Deliv (2011) 0.84
Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation. Int J Pharm (2005) 0.84
Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. Biomacromolecules (2011) 0.84
Toll-like receptor agonists: a patent review (2011 - 2013). Expert Opin Ther Pat (2014) 0.84
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand. J Med Chem (2012) 0.83
Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights. Pharm Res (2014) 0.83
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorg Med Chem Lett (2007) 0.83
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorg Med Chem (2008) 0.83
Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery. Methods Mol Biol (2011) 0.83
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components. J Med Chem (2010) 0.83
Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem (2010) 0.82
Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. J Med Chem (2004) 0.82
Simple synthetic toll-like receptor 2 ligands. Bioorg Med Chem Lett (2011) 0.82
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin. Bioorg Med Chem (2005) 0.82
Peptide-based subunit vaccine against hookworm infection. PLoS One (2012) 0.82
Peptide conjugation via CuAAC 'click' chemistry. Molecules (2013) 0.82
Oral vaccine delivery--new strategies and technologies. Curr Drug Deliv (2009) 0.82
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules (2013) 0.82
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem (2003) 0.81
Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem (2003) 0.81
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. Vaccine (2009) 0.81
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunol Cell Biol (2002) 0.81
Advances in peptide-based human papillomavirus therapeutic vaccines. Curr Top Med Chem (2012) 0.81
Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2. Vaccine (2009) 0.81
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery. Bioorg Med Chem (2007) 0.81
Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine (Lond) (2012) 0.80
Oral absorption and in vivo biodistribution of alpha-conotoxin MII and a lipidic analogue. Biochem Biophys Res Commun (2007) 0.80
Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. Eur J Pharm Sci (2002) 0.80
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models. Int J Pharm (2006) 0.80
Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products. Med Res Rev (2009) 0.80
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine (Lond) (2013) 0.80
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. J Med Chem (2006) 0.80
Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation. PLoS One (2012) 0.80
Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta (2006) 0.80
Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes. J Med Chem (2002) 0.79
Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res (2006) 0.79
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem (2008) 0.79
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis. Bioorg Med Chem (2010) 0.79
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. J Med Chem (2007) 0.79
Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. J Med Chem (2004) 0.79
Increased adjuvant activity of minimal CD8 T cell peptides incorporated into lipid-core-peptides. Immunol Cell Biol (2004) 0.78
M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus. Curr Drug Deliv (2013) 0.78
Versatile peptide dendrimers for nucleic acid delivery. J Pharm Sci (2005) 0.78
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. Nanomedicine (2010) 0.78
Microwave-assisted synthesis of difficult sequence-containing peptides using the isopeptide method. Org Biomol Chem (2013) 0.78
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. J Infect Dis (2006) 0.78
Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives. Bioorg Med Chem (2012) 0.78
Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. Bioorg Med Chem (2013) 0.78
Nanovaccines and their mode of action. Methods (2013) 0.78
Enhancement of oral drug absorption-effect of lipid conjugation on the enzymatic stability and intestinal permeability of l-Glu-l-Trp-NH(2). Bioorg Med Chem (2007) 0.78
Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation. J Org Chem (2006) 0.78
Effect of polymer grafting density on silica nanoparticle toxicity. Bioorg Med Chem (2012) 0.78
A novel synthetic adjuvant enhances dendritic cell function. Immunology (2008) 0.78
Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotides. Bioorg Med Chem Lett (2002) 0.78
Endomorphin derivatives with improved pharmacological properties. Curr Med Chem (2013) 0.78
Synthesis and in vitro evaluation of glycosyl derivatives of luteinizing hormone-releasing hormone (LHRH). Bioorg Med Chem (2013) 0.77
Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Indian J Med Res (2004) 0.77
In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs. J Pharm Sci (2010) 0.77
Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes. J Med Chem (2012) 0.77
Characterisation of a cell wall-anchored protein of Staphylococcus saprophyticus associated with linoleic acid resistance. BMC Microbiol (2012) 0.77
Lipid core peptide technology and group A streptococcal vaccine delivery. Expert Rev Vaccines (2004) 0.77
Stability, permeability and growth-inhibitory properties of gonadotropin-releasing hormone liposaccharides. Pharm Res (2014) 0.77
Cellular transport pathways of polymer coated gold nanoparticles. Nanomedicine (2011) 0.77
Recent advances in peptide-based subunit nanovaccines. Nanomedicine (Lond) (2014) 0.77
A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix. Eur J Pharm Biopharm (2007) 0.77
Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates. Curr Drug Deliv (2009) 0.77
Synthesis of a Streptococcus pyogenes vaccine candidate based on the M protein PL1 epitope. Bioorg Med Chem Lett (2008) 0.77
Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model. PLoS One (2012) 0.77